Effects of thyroid function on hemostasis, coagulation, and fibrinolysis: a Mendelian Randomization study
dc.rights.license | open | en_US |
dc.contributor.author | ELLERVIK, Christina | |
dc.contributor.author | MORA, Samia | |
dc.contributor.author | KUS, Aleksander | |
dc.contributor.author | ASVOLD, Bjorn Olav | |
dc.contributor.author | MAROULI, Eirini | |
dc.contributor.author | DELOUKAS, Panos | |
dc.contributor.author | STERENBORG, Rosalie B. T. M. | |
dc.contributor.author | TEUMER, Alexandre | |
dc.contributor.author | BURGESS, Stephen | |
dc.contributor.author | SABATER-LLEAL, Maria | |
dc.contributor.author | HUFFMAN, Jennifer | |
dc.contributor.author | JOHNSON, Andrew D. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | TREGOUET, David-Alexandre | |
dc.contributor.author | SMITH, Nicolas L. | |
dc.contributor.author | MEDICI, Marco | |
dc.contributor.author | DEVRIES, Paul S. | |
dc.contributor.author | CHASMAN, Daniel I. | |
dc.contributor.author | KJAERGAARD, Alisa D. | |
dc.date.accessioned | 2021-08-27T14:40:27Z | |
dc.date.available | 2021-08-27T14:40:27Z | |
dc.date.issued | 2021-07-01 | |
dc.identifier.issn | 1050-7256 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/110236 | |
dc.description.abstractEn | BACKGROUND: Untreated hypothyroidism is associated with acquired von Willebrand syndrome, and hyperthyroidism is associated with increased thrombosis risk. However, the causal effects of thyroid function on hemostasis, coagulation, and fibrinolysis are unknown. METHODS: In a two sample Mendelian Randomization (MR) study with genome-wide association variants, we assessed causality of genetically predicted hypothyroidism (N=134,641), normal-range TSH (N=54,288) and fT4 (N=49,269), hyperthyroidism (N=51,823), and thyroid peroxidase antibody positivity (TPOAb) (N=25,821) on coagulation (APTT, VWF, factor VIII, PT, factor VII, fibrinogen) and fibrinolysis (D-dimer, TPA, PAI1) from the CHARGE Hemostasis Consortium (N=2,583-120,246). Inverse-variance-weighted random effects was the main MR analysis followed by sensitivity analyses. Two-sided p<0.05 was nominally significant and p<0.0011[=0.05/(5 exposures x 9 outcomes)] was Bonferroni significant for the main MR analysis. RESULTS: Genetically increased TSH was associated with decreased VWF [beta(SE)=-0.020(0.006), p=0.001] and with decreased fibrinogen [beta(SE)=-0.008(0.002), p=0.001]. Genetically increased fT4 was associated with increased VWF [beta(SE)=0.028(0.011), p=0.012]. Genetically predicted hyperthyroidism was associated with increased VWF [beta(SE)=0.012(0.004), p=0.006] and increased FVIII [beta(SE)=0.013(0.005), p=0.007]. Genetically predicted hypothyroidism and hyperthyroidism were associated with decreased TPA [beta(SE)=-0.009(0.024), p=0.024] and increased TPA [beta(SE)=0.022(0.008), p=0.008], respectively. MR sensitivity analyses showed similar direction but lower precision. Other coagulation and fibrinolytic factors were inconclusive. CONCLUSIONS: In the largest genetic studies currently available, genetically increased TSH and fT4 may be associated with decreased and increased synthesis of VWF, respectively. Since Bonferroni correction may be too conservative given the correlation between the analyzed traits, we cannot reject nominal associations of thyroid traits with coagulation or fibrinolytic factors. | |
dc.language.iso | EN | en_US |
dc.subject.en | Coagulation | |
dc.subject.en | Fibrinolysis | |
dc.subject.en | Hemostasis | |
dc.subject.en | Hyperthyroidism | |
dc.subject.en | Hypothyroidism | |
dc.subject.en | Thyroid hormone | |
dc.subject.en | Thyroid peroxidase antibody | |
dc.subject.en | Thyrotropin | |
dc.title.en | Effects of thyroid function on hemostasis, coagulation, and fibrinolysis: a Mendelian Randomization study | |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1089/thy.2021.0055 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 34210154 | en_US |
dc.description.sponsorshipEurope | Program Initiative d’Excellence | en_US |
bordeaux.journal | Thyroid | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.team | VINTAGE | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.identifier.funderID | Université de Bordeaux | en_US |
hal.identifier | hal-03327938 | |
hal.version | 1 | |
hal.date.transferred | 2021-08-27T14:40:31Z | |
hal.export | true | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Thyroid&rft.date=2021-07-01&rft.eissn=1050-7256&rft.issn=1050-7256&rft.au=ELLERVIK,%20Christina&MORA,%20Samia&KUS,%20Aleksander&ASVOLD,%20Bjorn%20Olav&MAROULI,%20Eirini&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |